Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ACE | P12821 | 4/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | PPM1B | O75688 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16339806 | 0.83 | MME (0.47) | MMEALDH1A1PKMCYP2C19CYP1A2 | |
| SCHEMBL8565353 | 0.80 | MME (0.47) | MMEALDH1A1PKMCYP2C19CYP1A2 | |
| SCHEMBL18137281 | 0.78 | MAPT (0.42) | MMEALDH1A1PKMACESMN1; SMN2 | |
| SCHEMBL4594736 | 0.77 | MAPK1 (0.46) | MMEALDH1A1ACECYP2C19CYP1A2 | |
| SCHEMBL9291274 | 0.76 | MME (0.44) | MMEACECYP2C19CYP1A2 | |
| SCHEMBL8818604 | 0.76 | CYP2C19 (0.44) | MMEALDH1A1CYP2C19CYP1A2PPM1B | |
| SCHEMBL230931 | 0.75 | POLB (0.56) | MMEALDH1A1PKM | |
| SCHEMBL5162325 | 0.74 | ALDH1A1 (0.56) | MMEALDH1A1PKMACECYP2C19 | |
| SCHEMBL10703610 | 0.71 | ALDH1A1 (0.36) | MMEALDH1A1PKMACECYP2C19 | |
| SCHEMBL4794872 | 0.70 | ALDH1A1 (0.47) | MMEALDH1A1PKMACECYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0440298-A1 | Topical preparations for treating human nails | BROCADES PHARMA B.V. (NL) | 1991-08-07 | — | — | EP | disclosed |